D.E. Shaw & Co’s DarioHealth DRIO Stock Holding History

D.E. Shaw & Co’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,196	Closed	-$147K	–	5262
2022 Q2	$147K	Buy	1,196 +653	+120%	+$76.6K	﹤0.01%	4647
2022 Q1	$63K	Buy	+543	New	+$89.8K	﹤0.01%	5088

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

AWAM

Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co's DRIO Position: Q3 2022 in Review

D.E. Shaw & Co sold out of DarioHealth (DRIO) in Q3 2022, closing a stake of 1,196 shares — an estimated $147K sold.

D.E. Shaw & Co first reported a position in DRIO in Q1 2022 and held it in 2 quarters. The position peaked at $147K in Q2 2022. 45 funds tracked by Wall St. Rank hold DRIO as of Q3 2022.

D.E. Shaw & Co reported no remaining DarioHealth position as of Q3 2022 after selling out during the quarter.
D.E. Shaw & Co sold 1,196 DarioHealth shares in Q3 2022, an estimated $147K.
D.E. Shaw & Co first reported a position in DarioHealth in Q1 2022 and held it in 2 quarters.
D.E. Shaw & Co's DarioHealth position peaked at $147K in Q2 2022.
45 funds tracked by Wall St. Rank held DarioHealth as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.